Estimating the SARS-CoV2 infections detection rate and cumulative incidence in the World Health Organization African Region 10 months into the pandemic.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
04 11 2021
Historique:
pubmed: 5 11 2021
medline: 8 1 2022
entrez: 4 11 2021
Statut: epublish

Résumé

As of 03 January 2021, the WHO African region is the least affected by the coronavirus disease-2019 (COVID-19) pandemic, accounting for only 2.4% of cases and deaths reported globally. However, concerns abound about whether the number of cases and deaths reported from the region reflect the true burden of the disease and how the monitoring of the pandemic trajectory can inform response measures.We retrospectively estimated four key epidemiological parameters (the total number of cases, the number of missed cases, the detection rate and the cumulative incidence) using the COVID-19 prevalence calculator tool developed by Resolve to Save Lives. We used cumulative cases and deaths reported during the period 25 February to 31 December 2020 for each WHO Member State in the region as well as population data to estimate the four parameters of interest. The estimated number of confirmed cases in 42 countries out of 47 of the WHO African region included in this study was 13 947 631 [95% confidence interval (CI): 13 334 620-14 635 502] against 1 889 512 cases reported, representing 13.5% of overall detection rate (range: 4.2% in Chad, 43.9% in Guinea). The cumulative incidence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was estimated at 1.38% (95% CI: 1.31%-1.44%), with South Africa the highest [14.5% (95% CI: 13.9%-15.2%)] and Mauritius [0.1% (95% CI: 0.099%-0.11%)] the lowest. The low detection rate found in most countries of the WHO African region suggests the need to strengthen SARS-CoV-2 testing capacities and adjusting testing strategies.

Identifiants

pubmed: 34732273
doi: 10.1017/S0950268821002417
pii: S0950268821002417
pmc: PMC8712927
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e264

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Am J Trop Med Hyg. 2020 Aug;103(2):564-569
pubmed: 32484156
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Science. 2021 Jan 1;371(6524):27-28
pubmed: 33384364
JAMA Intern Med. 2020 Jul 21;:
pubmed: 32692365
Lancet Microbe. 2020 May;1(1):e12
pubmed: 32835324
PLoS One. 2020 Nov 5;15(11):e0241824
pubmed: 33152008
Science. 2021 Jan 1;371(6524):79-82
pubmed: 33177105
Lancet Infect Dis. 2021 Apr;21(4):e69-e70
pubmed: 32679085
JAMA Netw Open. 2020 May 1;3(5):e209666
pubmed: 32437575
Immunity. 2020 May 19;52(5):737-741
pubmed: 32433946
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Infect Chemother. 2020 Jun;52(2):154-164
pubmed: 32537961
Front Immunol. 2020 Jul 21;11:1817
pubmed: 32793245
BMJ Open. 2020 Oct 5;10(10):e043763
pubmed: 33020109
Clin Microbiol Infect. 2021 Mar;27(3):331-340
pubmed: 33228974
BMJ. 2021 Feb 17;372:n334
pubmed: 33597166
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Emerg Infect Dis. 2020 Jun;26(6):1339-1441
pubmed: 32168463
Lancet. 2020 May 30;395(10238):1669
pubmed: 32473665
Infect Dis Poverty. 2021 Mar 17;10(1):30
pubmed: 33731226
J Med Internet Res. 2020 Nov 19;22(11):e24248
pubmed: 33211026
Immunity. 2020 Jul 14;53(1):1-5
pubmed: 32610080
BMJ Glob Health. 2020 May;5(5):
pubmed: 32451366
Lancet. 2020 Oct 24;396(10259):1335-1344
pubmed: 32987007
Am J Trop Med Hyg. 2021 Feb 11;:
pubmed: 33571138
BMJ Glob Health. 2020 May;5(5):
pubmed: 32451367
Elife. 2021 Jun 30;10:
pubmed: 34190045

Auteurs

Benido Impouma (B)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.
Resolve to Save Lives, New York, New York, USA.

Franck Mboussou (F)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Cyrus Shahpar (C)

Resolve to Save Lives, New York, New York, USA.

Caitlin M Wolfe (CM)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.
College of Public Health, University of South Florida, Tampa, Florida, USA.

Bridget Farham (B)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

George Sie Williams (GS)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Humphrey Karamagi (H)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Roland Ngom (R)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Ngoy Nsenga (N)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Antoine Flahault (A)

Institute of Global Health, University of Geneva, Geneva, Switzerland.

Cláudia Torres Codeço (CT)

Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Zabulon Yoti (Z)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Francis Kasolo (F)

World Health Organization, Regional Office for Africa, Brazzaville, Congo.

Olivia Keiser (O)

Institute of Global Health, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH